// App-Quantinova.ai

36 : PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in head and neck cancers.

Researchers

Presenter

  • Revati Patil

Principal Investigators

  • Dadasaheb B. Akolkar

  • Darshana Patil

  • Pradip Devhare

  • Navin Srivastava

  • Pooja Fulmali

  • Shoeb Patel

  • Pradyumna Shejwalkar

  • Vineet Datta

  • Cynthe Sims

  • Ajay Srinivasan

  • Rajan Datar

Medical Centers

  • Datar Cancer Genetics Limited, Nasik, India

Locations

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

Biomarkers

  • Peripheral blood mononuclear cell

  • Circulating tumor cells

  • Programmed death-ligand 1

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved